GWAS meta-analysis provides new insights into uveal melanoma risk

OBJECTIVE: The aim of this research is to identify germline genetic variants that predispose to uveal melanoma (UM) using data from nine studies involving 5839 individuals with UM (3853 novel) and 349,863 healthy controls. METHODS: Five novel UM genome-wide association studies (GWAS) were performed and included for meta-analysis with four previously published UM GWAS. A fixed-effects inverse-variance weighted (IVW) meta-analysis was performed by combining data from these nine UM case-control cohorts. A follow-up transcriptome-wide association study (TWAS) was conducted to identify candidate target genes at UM risk loci. Genetic correlations with melanoma-related phenotypes were measured to elucidate UM's genetic architecture. RESULTS: . TWAS analysis indicates five potential target genes, including MOB3B, RBAK, and MTSS1, which have established links to multiple cancer types. We note a significant genetic correlation (rg = 0.31, P = 0.01) between UM and cutaneous melanoma (CM), and a non-significant but consistent correlation with naevus count (rg = 0.25, P = 0.08). CONCLUSIONS: This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2026-06-16
DOI
https://doi.org/10.1038/s41416-026-03499-7
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GWAS meta-analysis provides new insights into uveal melanoma risk

Nathan Ingold, Hauke Thomsen, Asta Försti, David C. Whiteman et al.
British Journal of Cancer
Ocular Oncology and Treatments
article

GWAS meta-analysis provides new insights into uveal melanoma risk

Nathan Ingold, Hauke Thomsen, Asta Försti, David C. Whiteman, Stuart MacGregor, Sarah E. Coupland, Vikas Chadha, Marc‐Henri Stern, Matthew H. Law, Kevin M. Brown, Catherine M. Olsen, Aaron B. Beasley, Julie Connolly, Lenha Mobuchon, Colleen M. Cebulla, Michael Zeschnigk, Peter A. Johansson, Antonia L. Pritchard, Elin S. Gray, Jane M. Palmer, Helen Kalirai, Ngoc‐Quynh Le, Samantha Barlow, Timothy Beckman, Lindsay A. McGrath, Bechrakis N.E, Kelly Brooks, Huanwei Wang, Colette Mustard, Jens F. Kiilgaard, Nick Hayward, William J. Glasson, Karin W. Wadt, Timothy Isaacs, Lindsey Byrne, Paul Cauchi, Gayle Williamson, Kari Hemminki, Mohamed H. Abdel-Rahman, G. J. M. Shanika R. Jayasinghe, Sunil K. Warrier, Matthew D’Mellow
article en

Abstract

OBJECTIVE: The aim of this research is to identify germline genetic variants that predispose to uveal melanoma (UM) using data from nine studies involving 5839 individuals with UM (3853 novel) and 349,863 healthy controls. METHODS: Five novel UM genome-wide association studies (GWAS) were performed and included for meta-analysis with four previously published UM GWAS. A fixed-effects inverse-variance weighted (IVW) meta-analysis was performed by combining data from these nine UM case-control cohorts. A follow-up transcriptome-wide association study (TWAS) was conducted to identify candidate target genes at UM risk loci. Genetic correlations with melanoma-related phenotypes were measured to elucidate UM's genetic architecture. RESULTS: . TWAS analysis indicates five potential target genes, including MOB3B, RBAK, and MTSS1, which have established links to multiple cancer types. We note a significant genetic correlation (rg = 0.31, P = 0.01) between UM and cutaneous melanoma (CM), and a non-significant but consistent correlation with naevus count (rg = 0.25, P = 0.08). CONCLUSIONS: This meta-analysis offers new insights into the genetic architecture of UM, highlights potential therapeutic targets, and explores the genetic relationship with CM and skin pigmentation.

British Journal of Cancer
Edith Cowan University (AU), National Institutes of Health (US), University of Liverpool (GB), Queensland University of Technology (AU), The University of Queensland (AU), The University of Western Australia (AU), German Cancer Research Center (DE), Charles University (CZ), QIMR Berghofer Medical Research Institute (AU), Heidelberg University (DE), Université Paris Sciences et Lettres (FR), Royal Perth Hospital (AU), Harry Perkins Institute of Medical Research (AU), Gartnavel General Hospital (GB), Rigshospitalet (DK), The Ohio State University Wexner Medical Center (US), MSB Medical School Berlin (DE), Office of the Director (US), Hopp Children's Cancer Center Heidelberg (DE), Essen University Hospital (DE), City Eye Centre (AU), National Cancer Institute (US), University of the Highlands and Islands (GB)
Openalex Percentile: Top 6%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.